Elixir Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity. The Companyâ€™s scientific founders identified that interactions between specific genes and enzymes can slow the aging process, and they are developing compounds that stimulate these interactions and will be used to treat a range of diseases of aging, including metabolic disease.
Past Team (5)Update
Funding Rounds (2) - $58MUpdate
Healthcare Venture Capital
Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides...
ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs,...
Physic Ventures, based in San Francisco, provides capital and support to entrepreneurs focused on...
CDIB BioScience Venture Management (CBVM) is a life science venture management company with...
JAFCO Ventures is an independent venture capital firm investing in emerging technology companies...
biotechnology investment companies
300 Putnam Avenue
Cambridge, MA 02139